期刊文献+

老年冠心病患者代谢综合征危险因素分析 被引量:2

下载PDF
导出
摘要 目的:回顾性分析老年冠心病患者中代谢综合征(MS)危险因素的分布情况,为早期干预提供依据。方法:将300例老年冠心病患者[冠心病组,年龄(68.1±6.3)岁]冠心病诊断当年、前一年、前二年及前三年的代谢综合征危险因素与300例老年非冠心病患者[对照组年龄(68.2±8.3)岁]相比较。结果:两组在年龄、体重指数、收缩压、舒张压、空腹血糖及总胆固醇上无明显差异。低密度脂蛋白胆固醇冠心病组各年均显著高于非冠心病组;甘油三酯(TG)诊断当年及前一年明显高于对照组,而高密度脂蛋白胆固醇(HDL-C)显著低于后者。冠心病组MS的发生率(诊断当年为22.36%)明显高于对照组(P<0.05)。冠心病组(1.22%)及(1.7%)低HDL-C的发生率均非常低。结论:老年冠心病患者常伴多种严重代谢异常,重点加强对高血压及血脂的控制,可望减少心血管事件的发生。
出处 《实用医学杂志》 CAS 2007年第1期66-67,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献7

  • 1贾伟平,项坤三,陈蕾,陆俊茜,包玉倩,吴元民,姜素英.两种代谢综合征工作定义在上海地区人群中应用的比较[J].中华医学杂志,2004,84(7):534-538. 被引量:97
  • 2Gorter P M,Olijhoek J K,Graaf Y,et al.Prevalence of the metabolic syndrome in patients with coronary heart disease,cerebrovascular disease,peripheral arterial disease or abdominal aortic aneurysm[J].Atherosclerosis,2004,173(3):363-369.
  • 3Solymose B C,Bourassa M G,Lesperance J,et al.Incidence and clinical characteristics of the the metabolic syndrome in patients with coronary artery disease[J].Coronary Artery Disease,2003,14(2):207-212.
  • 4谢玉才,李黎,张瑞岩,龚佩华,吴树理,吴立群,陆国平,沈卫峰.冠心病合并代谢综合征患者的长期预后分析[J].上海第二医科大学学报,2005,25(8):788-791. 被引量:10
  • 5陶红,米树华,赵全明,田磊,戴文龙,周芸.青中年冠心病患者代谢综合征危险因素的分布与聚集状况分析[J].临床心血管病杂志,2005,21(7):387-389. 被引量:10
  • 6Wong N D,Pio J R,Franklin S S,et al.Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome[J].Am J Cardiol,2003,91 (10):1421-1426.
  • 7Nigam A,Bourassa M G,Fortia A,et al.The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease[J].Am Heart J,2006,151(2):514-521.

二级参考文献27

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3063
  • 2Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002,287: 356-359.
  • 3Deedwania PC. Metabolic syndrome and vascular disease. Is nature or nurture leading the new epidemic of cardiovascular disease[J]? Circulation, 2004,109: 2-4.
  • 4Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united states adults[J]. Circulation, 2004,110: 1245-1250.
  • 5Wong ND, Pio JR, Franklin SS, et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome[J]. Am J Cardiol, 2003, 91: 1421-1426.
  • 6Pyorala K, Ballantyne CM, Gumbiner B, et al. Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabo-lic syndrome[J]. Diabetes Care, 2004, 27: 1735-1740.
  • 7Gorter PM, Olijhoek JK, Graaf Y, et al. Prevalence of the metabo-lic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm[J]. Atherosclerosis, 2004,173: 363-369.
  • 8Solymoss BC, Bourassa MG, Lesperance J, et al. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease[J]. Coronary Artery Disease, 2003, 14: 207-212.
  • 9Grundy SM, Cleeman JI, Merz NB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines[J]. Circulation, 2004,110:227-239.
  • 10Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24:683-689.

共引文献114

同被引文献17

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部